Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
N-terminal asparagine amidase pseudogene 2 (NTAN1P2) is a human pseudogene, meaning it is a nonfunctional DNA sequence derived from a gene that usually encodes a protein, in this case homologous to N-terminal asparagine amidase. Pseudogenes like NTAN1P2 do not produce functional proteins due to presence of disabling mutations (such as premature stops or frameshifts), and are typically considered "junk DNA" or remnants of evolution[3]. However, some pseudogenes are transcribed as noncoding RNAs and may participate in gene regulation by acting as microRNA decoys or through other noncoding RNA mechanisms[2][4]. There is currently no evidence that NTAN1P2 plays a specific biological role or is involved in disease or drug targeting. Its main relevance is as a marker for evolutionary gene history and potentially for regulatory studies involving noncoding RNAs derived from pseudogenes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on N-terminal asparagine amidase pseudogene 2 (NTAN1P2).